2-166054630-G-GCA
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001165963.4(SCN1A):c.602+6_602+7dupTG variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000552 in 1,611,682 control chromosomes in the GnomAD database, including 10 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00034 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00057 ( 10 hom. )
Consequence
SCN1A
NM_001165963.4 splice_region, intron
NM_001165963.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.658
Publications
1 publications found
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 2-166054630-G-GCA is Benign according to our data. Variant chr2-166054630-G-GCA is described in ClinVar as [Likely_benign]. Clinvar id is 257623.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000335 (51/152078) while in subpopulation SAS AF = 0.0106 (51/4830). AF 95% confidence interval is 0.00825. There are 0 homozygotes in GnomAd4. There are 37 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 51 AD,Unknown gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN1A | ENST00000674923.1 | c.602+7_602+8insTG | splice_region_variant, intron_variant | Intron 7 of 28 | NM_001165963.4 | ENSP00000501589.1 | ||||
SCN1A | ENST00000303395.9 | c.602+7_602+8insTG | splice_region_variant, intron_variant | Intron 6 of 27 | 5 | ENSP00000303540.4 | ||||
SCN1A | ENST00000375405.7 | c.602+7_602+8insTG | splice_region_variant, intron_variant | Intron 4 of 25 | 5 | ENSP00000364554.3 | ||||
SCN1A | ENST00000409050.2 | c.602+7_602+8insTG | splice_region_variant, intron_variant | Intron 6 of 27 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes AF: 0.000336 AC: 51AN: 151960Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
51
AN:
151960
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00118 AC: 295AN: 250564 AF XY: 0.00160 show subpopulations
GnomAD2 exomes
AF:
AC:
295
AN:
250564
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000574 AC: 838AN: 1459604Hom.: 10 Cov.: 31 AF XY: 0.000837 AC XY: 608AN XY: 726116 show subpopulations
GnomAD4 exome
AF:
AC:
838
AN:
1459604
Hom.:
Cov.:
31
AF XY:
AC XY:
608
AN XY:
726116
show subpopulations
African (AFR)
AF:
AC:
2
AN:
33394
American (AMR)
AF:
AC:
0
AN:
44570
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26042
East Asian (EAS)
AF:
AC:
0
AN:
39570
South Asian (SAS)
AF:
AC:
800
AN:
86216
European-Finnish (FIN)
AF:
AC:
0
AN:
53370
Middle Eastern (MID)
AF:
AC:
4
AN:
5746
European-Non Finnish (NFE)
AF:
AC:
2
AN:
1110442
Other (OTH)
AF:
AC:
30
AN:
60254
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
40
81
121
162
202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000335 AC: 51AN: 152078Hom.: 0 Cov.: 32 AF XY: 0.000498 AC XY: 37AN XY: 74352 show subpopulations
GnomAD4 genome
AF:
AC:
51
AN:
152078
Hom.:
Cov.:
32
AF XY:
AC XY:
37
AN XY:
74352
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41526
American (AMR)
AF:
AC:
0
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5184
South Asian (SAS)
AF:
AC:
51
AN:
4830
European-Finnish (FIN)
AF:
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67928
Other (OTH)
AF:
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
23
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Oct 04, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
The variant is found in EPILEPSY,INFANT-EPI panel(s). -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Developmental and epileptic encephalopathy Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Severe myoclonic epilepsy in infancy;C1858673:Generalized epilepsy with febrile seizures plus, type 2;C1864987:Migraine, familial hemiplegic, 3;C5543353:Developmental and epileptic encephalopathy 6B Benign:1
Feb 13, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Oct 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
SCN1A: BP4, BS1, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.